NCT04244552 2023-12-29A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesAtreca, Inc.Phase 1 Terminated87 enrolled
NCT00550771 2017-06-07Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)Merck Sharp & Dohme LLCPhase 2 Completed181 enrolled 9 charts